Park Boyoung, Kim Dongwon, Kim Jiyoung, Lee Bom Yi, Yoon Junghyun, Kim Sung-Won
Department of Preventive Medicine, Hanyang University College of Medicine, Seoul, Korea.
Department of Surgery, Daerim St. Mary's Hospital, Seoul, Korea.
Cancer Res Treat. 2022 Apr;54(2):375-382. doi: 10.4143/crt.2021.449. Epub 2021 Aug 9.
This study investigated the attitudes toward risk-reducing mastectomy (RRM) and risk-reducing salpingo-oophorectomy (RRSO) as cancer prevention options for BRCA1/2 carriers in healthy, young, unmarried Korean women.
A nationally representative sample of 600 women, aged 20-39 years, completed a questionnaire on sociodemographic variables, preference for genetic testing, and intention to undergo risk-reducing surgeries after receiving information on the cancer risk of BRCA1/2 mutations and benefits of risk-reducing surgeries.
A total of 54.7% and 57.7% had the intention to undergo RRM and RRSO, respectively, on the assumption that they were BRCA1/2 carriers. Older age and no intention to undergo genetic testing were associated with a reduced likelihood of undergoing RRM (odds ratio [OR], 0.30; 95% confidence interval [CI], 0.14 to 0.61 for age 35-39 years and OR, 0.35; 95% CI, 0.20 to 0.62 for no intention for genetic testing) and RRSO (OR, 0.39; 95% CI, 0.19 to 0.79 for age 35-39 years and OR, 0.30; 95% CI, 0.17 to 0.53 for no intention for genetic testing). Women who chose to be single were likely to undergo risk-reducing surgeries (OR, 1.67; 95% CI, 1.07 to 2.60 for RRM and OR, 1.56; 95% CI, 1.00 to 2.44 for RRSO).
More than 50% of healthy, unmarried, young Korean women were inclined to undergo prophylactic surgeries if they were BRCA1/2 mutation carriers. Further studies on decision-making process for cancer prevention in individuals at high risk for cancer need to be conducted.
本研究调查了健康、年轻、未婚的韩国女性对降低风险的乳房切除术(RRM)和降低风险的输卵管卵巢切除术(RRSO)作为BRCA1/2携带者癌症预防选择的态度。
对600名年龄在20 - 39岁的具有全国代表性的女性样本进行调查,她们在了解BRCA1/2突变的癌症风险和降低风险手术的益处后,完成了一份关于社会人口统计学变量、基因检测偏好以及接受降低风险手术意愿的问卷。
假设她们是BRCA1/2携带者,分别有54.7%和57.7%的人有接受RRM和RRSO的意愿。年龄较大以及不打算进行基因检测与接受RRM(优势比[OR],0.30;95%置信区间[CI],35 - 39岁为0.14至0.61,不打算进行基因检测为OR,0.35;95% CI,0.20至0.62)和RRSO(OR,0.39;95% CI,35 - 39岁为0.19至0.79,不打算进行基因检测为OR,0.30;95% CI,0.17至0.53)的可能性降低相关。选择单身的女性更有可能接受降低风险手术(RRM的OR为1.67;95% CI,1.07至2.60;RRSO的OR为1.56;95% CI,1.00至2.44)。
如果是BRCA1/2突变携带者,超过50%的健康、未婚、年轻韩国女性倾向于接受预防性手术。需要对癌症高风险个体的癌症预防决策过程进行进一步研究。